Spasler-P (hyoscine): Uses, Dosage & Side Effects

What it's for (Indications)

Hyoscine, specifically its butylbromide salt (e.
g.
, as often found in products like Spasler-P), is primarily indicated for the symptomatic relief of acute spasmodic conditions affecting the gastrointestinal tract, including irritable bowel syndrome (IBS), biliary colic, and renal colic.
It effectively targets visceral smooth muscle spasm, reducing pain and discomfort associated with these conditions.
In its hydrobromide form, administered via transdermal patch or injection, hyoscine is widely utilized for the prevention of motion sickness and postoperative nausea and vomiting (PONV), leveraging its central antiemetic properties.
Additionally, hyoscine hydrobromide serves as a preoperative medication to reduce salivary and bronchial secretions, thereby minimizing the risk of aspiration during anesthesia and surgery.
Its potent anticholinergic properties make it efficacious in relaxing smooth muscles and decreasing glandular secretions, offering therapeutic benefit across a spectrum of conditions characterized by visceral spasms, hypermotility, or excessive secretions.
The specific formulation and salt of hyoscine dictate its primary indications and routes of administration, with butylbromide mainly targeting peripheral smooth muscle spasms due to its limited ability to cross the blood-brain barrier, resulting in fewer central nervous system side effects.

Dosage Information

Type	Guideline
Standard	Dosage of hyoscine varies significantly based on the specific salt (butylbromide or hydrobromide), formulation (oral tablet, injectable solution, transdermal patch), and the medical condition being treated. For oral hyoscine butylbromide (e.g., typical for spasm relief), adult doses for gastrointestinal spasms may range from 10 mg to 20 mg, administered three to five times daily as needed. Injectable forms (intravenous, intramuscular, or subcutaneous) of hyoscine butylbromide for acute severe spasms might involve 20 mg doses, which can be repeated after a certain interval if necessary, up to a maximum daily dose. For the prevention of motion sickness or postoperative nausea and vomiting, the transdermal patch of hyoscine hydrobromide typically delivers approximately 1 mg over 72 hours, applied behind the ear at least 4 hours before the anticipated event. Preoperative injectable doses of hyoscine hydrobromide usually range from 0.2 mg to 0.6 mg. Pediatric dosages are significantly lower and must be carefully calculated based on weight and age, and specific guidelines should be followed. It is crucial to emphasize that all dosages should be individualized by a healthcare professional, considering patient age, renal and hepatic function, co-morbidities, and concomitant medications to minimize adverse effects and optimize therapeutic outcomes. Self-medication or exceeding prescribed doses is strongly discouraged.

Type

Guideline

Standard

Dosage of hyoscine varies significantly based on the specific salt (butylbromide or hydrobromide), formulation (oral tablet, injectable solution, transdermal patch), and the medical condition being treated. For oral hyoscine butylbromide (e.g., typical for spasm relief), adult doses for gastrointestinal spasms may range from 10 mg to 20 mg, administered three to five times daily as needed. Injectable forms (intravenous, intramuscular, or subcutaneous) of hyoscine butylbromide for acute severe spasms might involve 20 mg doses, which can be repeated after a certain interval if necessary, up to a maximum daily dose. For the prevention of motion sickness or postoperative nausea and vomiting, the transdermal patch of hyoscine hydrobromide typically delivers approximately 1 mg over 72 hours, applied behind the ear at least 4 hours before the anticipated event. Preoperative injectable doses of hyoscine hydrobromide usually range from 0.2 mg to 0.6 mg. Pediatric dosages are significantly lower and must be carefully calculated based on weight and age, and specific guidelines should be followed. It is crucial to emphasize that all dosages should be individualized by a healthcare professional, considering patient age, renal and hepatic function, co-morbidities, and concomitant medications to minimize adverse effects and optimize therapeutic outcomes. Self-medication or exceeding prescribed doses is strongly discouraged.

Safety & Warnings

Common Side Effects

Hyoscine, particularly due to its potent anticholinergic properties, can induce a range of side effects that are generally dose-dependent and vary in severity.
Common adverse reactions include characteristic anticholinergic effects such as dry mouth (xerostomia), blurred vision, cycloplegia, mydriasis, and photophobia due to its impact on ocular accommodation and pupil size.
Other frequent systemic side effects are constipation, urinary retention (especially in men with prostatic hypertrophy), drowsiness, dizziness, and mild confusion.
Cardiovascular effects may include tachycardia and palpitations.
In elderly or particularly sensitive individuals, or with higher doses, central nervous system effects such as disorientation, hallucinations, agitation, and even paradoxical excitement or psychotic reactions can occur.
Less common but potentially serious side effects might include allergic reactions (e.
g.
, rash, urticaria, anaphylaxis), acute angle-closure glaucoma (especially in predisposed individuals), and paralytic ileus.
Patients should be advised to report any persistent or severe side effects to their healthcare provider promptly.
It's important to differentiate between the systemic effects of hyoscine hydrobromide, which readily crosses the blood-brain barrier, and the predominantly peripheral effects of hyoscine butylbromide, which generally has fewer central nervous system side effects due to its limited blood-brain barrier penetration.

Serious Warnings

Black Box Warning: Hyoscine (scopolamine) does not currently carry a formal Black Box Warning from the U.S. Food and Drug Administration (FDA) for its commonly approved indications. However, due to its significant anticholinergic properties and potential for serious adverse effects, particularly in vulnerable populations, several critical warnings and precautions must be rigorously observed by healthcare providers and patients. **Serious Warnings:** 1. **Central Nervous System (CNS) Effects:** Systemic administration of hyoscine, especially the hydrobromide salt, can cause significant CNS effects, including drowsiness, dizziness, confusion, disorientation, hallucinations, agitation, and even psychotic reactions. Elderly patients are particularly susceptible to these adverse CNS events. Patients should be warned about impaired ability to perform tasks requiring mental alertness, such as driving or operating machinery. Concurrent use with alcohol or other CNS depressants will exacerbate these effects. 2. **Acute Angle-Closure Glaucoma Risk:** Hyoscine's mydriatic effect can precipitate an acute attack of angle-closure glaucoma in predisposed individuals with shallow anterior chambers. A thorough ophthalmic evaluation, including assessment for narrow anterior chamber angles, may be warranted before initiating therapy, especially in older patients. 3. **Urinary Retention:** Due to its anticholinergic effects on the bladder and urinary tract smooth muscle, hyoscine can cause or exacerbate urinary retention, particularly in patients with pre-existing conditions like prostatic hypertrophy or other forms of bladder neck obstruction. 4. **Gastrointestinal Complications:** Hyoscine is contraindicated or should be used with extreme caution in patients with conditions like paralytic ileus, pyloric stenosis, or toxic megacolon, as it can worsen these conditions by profoundly inhibiting gastrointestinal motility and potentially leading to bowel perforation. 5. **Withdrawal Symptoms:** Prolonged use of transdermal hyoscine patches can lead to significant withdrawal symptoms (e.g., dizziness, nausea, vomiting, headache) upon abrupt discontinuation. Patients should be advised against abrupt cessation, and gradual tapering may be considered if clinically appropriate. 6. **Exacerbation of Pre-existing Conditions:** Caution is necessary in patients with cardiac tachyarrhythmias, congestive heart failure, or myasthenia gravis, as hyoscine can worsen these conditions by increasing heart rate or interfering with neuromuscular function. Close monitoring is essential in such patients.
Hyoscine should be used with extreme caution in certain patient populations and clinical conditions due to its potent anticholinergic properties.
It can significantly exacerbate conditions such as narrow-angle glaucoma, prostatic hypertrophy, or any form of urinary tract obstruction, potentially leading to increased intraocular pressure or acute urinary retention.
Patients with pre-existing tachycardia or cardiac insufficiency, particularly those with underlying cardiac diseases, should be closely monitored, as hyoscine can increase heart rate and exacerbate arrhythmias.
Caution is also advised in individuals with myasthenia gravis, as anticholinergic agents can worsen muscle weakness.
In cases of severe ulcerative colitis, the potential for toxic megacolon is increased with anticholinergic agents.
Elderly patients are particularly susceptible to central nervous system side effects, including confusion, agitation, and hallucinations, even at therapeutic doses, necessitating careful dose titration and close monitoring.
Hyoscine can impair the ability to drive or operate machinery, and patients should be advised against such activities until they are aware of how the medication affects them.
Concurrent use with alcohol or other central nervous system depressants can potentiate drowsiness and dizziness.
Discontinuation of transdermal hyoscine after prolonged use can lead to withdrawal symptoms such as dizziness, nausea, vomiting, and headache; therefore, gradual tapering may be considered if feasible to mitigate these effects.
Patients with fever or in a hot environment should use hyoscine with caution, as it can reduce sweating and potentially lead to hyperthermia.

How it Works (Mechanism of Action)

Hyoscine functions as a competitive antagonist of muscarinic acetylcholine receptors, thereby inhibiting the actions of acetylcholine at postganglionic parasympathetic nerve endings throughout the body. This antagonism leads to a broad range of anticholinergic effects. Specifically, in the gastrointestinal, genitourinary, and biliary tracts, hyoscine exerts a potent antispasmodic effect by relaxing smooth muscle and reducing motility and tone, which is particularly beneficial in conditions like irritable bowel syndrome or colic by alleviating painful spasms. In the eye, its blockade of muscarinic receptors causes mydriasis (pupil dilation) and cycloplegia (paralysis of accommodation). In various glandular tissues, hyoscine significantly reduces exocrine secretions, including salivary, bronchial, and sweat gland output, making it useful preoperatively to decrease the risk of aspiration during anesthesia and surgical procedures. When hyoscine hydrobromide crosses the blood-brain barrier, it can exert central nervous system effects, including sedation, amnesia, and antiemetic properties, primarily by blocking muscarinic receptors in the vestibular nuclei and the chemoreceptor trigger zone, which are integral in the pathways for motion sickness and postoperative nausea/vomiting. Hyoscine butylbromide, in contrast, has limited penetration across the blood-brain barrier and thus primarily exerts its anticholinergic effects peripherally, minimizing central nervous system side effects while effectively treating visceral spasms.